光学透明频率选择表面的设计研究

以氟化镁为基底材料, 采用基底、金属网栅与频率选择表面一体化设计方法设计了一种雷达波与光学波段双带通的结构. 利用模式匹配法对设计结构的传输特性进行了仿真研究, 并将设计结果与制备样件的测试结果进行了对比分析. 结果发现: 采用一体化设计的方法设计光学透明频率选择表面, 不仅能够快速得到电场基函数而且还能够准确预估其谐振尺寸, 从而在提高计算效率的同时避免了模式互作用零点的出现. 采用一体化设计方法获得了具有稳定滤波特性的光学透明频率选择表面, 为雷达/红外双模制导头罩的电磁屏蔽技术和隐身技术提供了一种有效技术方案. 关键词： 复合制导 频率选择表面 金属网栅 一体化设计     

超光滑加工的后置处理算法研究

为了精确控制超光滑加工过程中磨头的运动轨迹,从而实现光学元件材料去除的均匀稳定,研究了超光滑加工的后置处理算法。分析了超光滑加工工艺的特点和相应的超光滑机床的机械结构,建立了机床的坐标系统,构造了机床的运动学模型。对于光学元件母线为任意平面曲线的情况,研究了磨头运动轨迹的等误差直线逼近算法。在曲率半径为290mm,相对口径为1∶2.9的凹球面上进行了超光滑加工实验。结果表明,利用所述算法可以精确地控制磨头的运动轨迹,从而保证材料去除的稳定性。     

液芯光纤中溶液吸收和荧光的性质对CS2受激拉曼散射阈值的影响

利用液芯光纤技术研究了不同浓度的β-Carotene的CS2溶液的吸收与荧光的特性对CS2的一、二阶Stokes谱线阈值的影响.实验发现随溶液浓度(10-8-10-6 mol/L)增加,CS2的一阶Stokes谱线的激发阈值相对变高;并且与纯CCS2芯液的受激拉曼散射相比较,在低抽运能量激发下,就观察到CS2的二阶Stokes谱线.这主要是由于在CS2的受激拉曼谱线产生的过程中,β-Carotene的CS2溶液的吸收和荧光共同影响了CS2的一、二阶Stokes谱线的阈值.我们进行了理论上的拟合与分析,其结果与实验符合很好.     

双偏振结构保偏光纤偏振器的研制

提出了保偏光纤偏振器的一种串联结构,即双偏振结构,报道了研制的结果。并通过对单偏振结构和双偏振结构器件测试结果的比较,得出双偏振结构的保偏光纤偏振器可使器件达到高消光比,并且有稳定的温度特性。     

超疏水聚合物表面的水滴蒸发模拟

基于质量守恒和Fick第一定律，模拟了水滴在超疏水聚合物表面的蒸发全过程．研究从以往的接触角<90±扩展到>150±，液滴形貌扩展为椭球球帽模型进行疏水表面蒸发模拟．水滴在超疏水PC和FPU/PMMA表面蒸发的实验结果显示，计算的椭球球帽模型可以更好的反映出液滴接触角和高度的变化情况，并且不同聚合物表面接触角的相同变化趋势也揭示出微-纳二级结构表面结构不仅影响液滴接触角，也影响液滴蒸发模式．     

新型风成像干涉仪温度补偿理论研究

简述了高层大气风场被动式遥感探测的基本原理;论述了新型风成像干涉仪宽场、消色差、温度补偿理论,针对目前国际上采用的风成像干涉仪补偿方法的不足,从理论上进行了分析与讨论,给出了四层介质的优化补偿理论和方案.模拟结果表明,该补偿可完全理想地消去单色光的温差,且复色光的温差补偿要比现有的方法提高1—2个量级.该研究为设计宽场、消色差、温度补偿的新型风成像干涉仪和提高风场探测精度提供了重要的理论依据和实践指导.     

Alpha Decay of the Neutron-deficient Isotopes 215,216U

The most neutron-deficient isotopes 215;216U were produced in the complete-fusion reaction 180W(40Ar, 4-5n)215,216U. Evaporation residues recoiled from the target were separated in-flight from the primary beam by the gas-filled recoil separator SHANS and subsequently identified on the basis of correlated -decay chains. Two -decaying states were identified in 216U, one for the ground state and the other for the isomeric state with 8+(h9=2f7=2) configuration. The -decay properties for 215;216U and the systematics of 8+ isomeric state in N =124,126 isotones were investigated.     

Perturbative Power Counting,Lowest-Index Operators and Their Renormalization in Standard Model Effective Field Theory

We study two aspects of higher dimensional operators in standard model effective field theory.We first introduce a perturbative power counting rule for the entries in the anomalous dimension matrix of operators with equal mass dimension.The power counting is determined by the number of loops and the difference of the indices of the two operators involved,which in turn is defined by assuming that all terms in the standard model Lagrangian have an equal perturbative power.Then we show that the operators with the lowest index are unique at each mass dimension d,i.e.,(H~?H)~(d/2)for even d≥4,and(L~TεH)C(L~TεH)~T(H~?H)~((d-5)/2)for odd d≥5.Here H,L are the Higgs and lepton doublet,andε,C the antisymmetric matrix of rank two and the charge conjugation matrix,respectively.The renormalization group running of these operators can be studied separately from other operators of equal mass dimension at the leading order in power counting.We compute their anomalous dimensions at one loop for general d and find that they are enhanced quadratically in d due to combinatorics.We also make connections with classification of operators in terms of their holomorphic and anti-holomorphic weights.     

Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection

Cepharanthine (CEP) has excellent anti-SARS-CoV-2 properties, indicating its favorable potential for COVID-19 treatment. However, its application is challenged by its poor dissolubility and oral bioavailability. The present study aimed to improve the bioavailability of CEP by optimizing its solubility and through a pulmonary delivery method, which improved its bioavailability by five times when compared to that through the oral delivery method (68.07% vs. 13.15%). An ultra-performance liquid chromatography tandem-mass spectrometry (UPLC-MS/MS) method for quantification of CEP in rat plasma was developed and validated to support the bioavailability and pharmacokinetic studies. In addition, pulmonary fibrosis was recognized as a sequela of COVID-19 infection, warranting further evaluation of the therapeutic potential of CEP on a rat lung fibrosis model. The antifibrotic effect was assessed by analysis of lung index and histopathological examination, detection of transforming growth factor (TGF)-β1, interleukin-6 (IL-6), α-smooth muscle actin (α-SMA), and hydroxyproline level in serum or lung tissues. Our data demonstrated that CEP could significantly alleviate bleomycin (BLM)-induced collagen accumulation and inflammation, thereby exerting protective effects against pulmonary fibrosis. Our results provide evidence supporting the hypothesis that pulmonary delivery CEP may be a promising therapy for pulmonary fibrosis associated with COVID-19 infection.     

HL-2M 装置运行控制技术初步研究

重点介绍了 HL-2M 装置的运行技术和初步的等离子体控制实验结果,包括等离子体放电方案设计、 线圈电流控制、击穿阶段零场匹配和等离子体电流以及位移的控制。为了降低放电运行风险,HL-2M 装置初始放 电采用了简化的放电方案,通过整定 PID 参数实现了线圈电流控制,在击穿阶段获得了 10V 以上的环电压和较大 范围的零场区域,成功实现等离子体击穿。最后,投入了等离子体电流和水平位移反馈控制算法,成功将等离子 体放电脉宽提升至 200ms 以上,且维持 I_p≥100kA 的时间超过了 100ms,上述结果表明 HL-2M 装置运行控制技术 得到了初步的检验。